Regulation of Mcl-1 expression in rheumatoid arthritis synovial macrophages

Hongtao Liu1, QiQuan Huang, Bo Shi

  • 1Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.

Arthritis and Rheumatism
|September 30, 2006
PubMed
Abstract

Insights

Mcl-1 protein is elevated in rheumatoid arthritis (RA) joint macrophages, promoting their survival. Inhibiting Mcl-1 or its signaling pathways induces apoptosis, suggesting Mcl-1 as a therapeutic target for RA.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) persistence may involve resistance to apoptosis.
  • Mcl-1, an antiapoptotic protein from the Bcl-2 family, is investigated in RA.

Purpose of the Study:

  • To characterize Mcl-1 expression, regulation, and function in RA synovial macrophages.
  • To explore Mcl-1 as a potential therapeutic target in RA.

Main Methods:

  • Isolated mononuclear cells from RA synovial fluid (SF).
  • Quantified Mcl-1 expression via flow cytometry, PCR, and immunoblotting.
  • Inhibited Mcl-1 using siRNA and PI 3-kinase/STAT-3 pathway inhibitors.

Main Results:

  • Mcl-1 expression was higher in RA synovial macrophages compared to controls.
  • Inhibiting PI 3-kinase/Akt-1 or STAT-3 pathways reduced Mcl-1 and induced apoptosis.
  • Mcl-1 siRNA transfection led to apoptotic cell death in RA synovial macrophages.

Conclusions:

  • Mcl-1 is crucial for RA synovial macrophage survival.
  • Mcl-1 represents a potential therapeutic target for rheumatoid arthritis.